Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03209830 Completed - Clinical trials for Aneurysmal Subarachnoid Hemorrhage

Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid Hemorrhage

Start date: September 5, 2017
Phase: Phase 2
Study type: Interventional

Many people who have undergone subarachnoid hemorrhage from an aneurysm (an artery of a vein in the brain) struggle with a pronounced fatigue as well as a number of other sequelae such as impaired concentration, memory deficits and emotional problems. Exhaustion is often permanent and can lead to a significant worsening of quality of life and be the cause of disability. This condition does not only have major consequences for the individual who is affected, but also for their families and for society. So far no effective treatment for fatigue has been found. The drug OSU6162 has shown a beneficial effect on fatigue and other impairments after stroke and after traumatic brain injury. There is good reason to believe that OSU6162 can also improve fatigue and other impairments after aneurysm bleeding and thus increase the chance of returning to the level of daily function they had before the bleeding. The study is double blinded and measures the effect of OSU6162 and placebo on fatigue and neuropsychological function.

NCT ID: NCT03209804 Completed - Clinical trials for Intracranial Arteriovenous Malformations

Surgical Management of Cerebral Arteriovenous Malformations Within Hybrid Operation Room

SMAVMHR
Start date: June 2016
Phase: N/A
Study type: Interventional

To evaluate the clinical benefits and risks of hybrid operating techniques in management of cerebral arteriovenous malformations.

NCT ID: NCT03209284 Completed - Clinical trials for Atrophy of Edentulous Maxillary Alveolar Ridge

Influence of Anatomy of Maxillary Sinus on New Bone Formation After Transcrestal Augmentation Procedures

SLSS
Start date: July 15, 2014
Phase:
Study type: Observational

The aim of this study is to analyze neoformed bone after maxillary sinus lifting with transcrestal approach, in atrophic crests (≤5 mm residual bone height). Clinical and laboratory data will be related to maxillo breast anatomy.

NCT ID: NCT03209245 Completed - Clinical trials for Allergen Immunotherapy in Elderly Patients

House Dust Mite Injection Immunotherapy in Elderly Patients.

HDMeld
Start date: April 10, 2014
Phase: Phase 3
Study type: Interventional

Background. Immunotherapy in elderly patients is controversial, and there is still not much evidences supporting this treatment's safety and efficacy in this population. This study was performed to evaluate the safety and efficacy of specific injection immunotherapy for house dust mite allergens in patients over 65 years of age with allergic rhinitis and a confirmed allergy to house dust mites. The primary endpoint was the change from baseline in the mean average adjusted symptom score (AAdSS) and the total combined rhinitis score (TCRS) difference in the least square means in the label in comparison to placebo. Materials and methods. The study with double blind, placebo controlled trial was conducted in one centre. Fifty eight elderly patients with house dust mites allergy and AR were individually randomized in comparable numbers to one of two parallel groups: two years perennial AIT with the use Purethal Mites or placebo. Symptoms and medication score were presented as AAdSS and TCRS. Quality of life based on Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), serum allergen specific IgG4 to D.pteronyssinus and D. farinae and Der p1 and Der p2 were monitoring.

NCT ID: NCT03208894 Completed - Clinical trials for Transient Tachypnea of the Newborn

Role of Salbutamol and Furosemide in TTN

Start date: November 1, 2016
Phase: Phase 3
Study type: Interventional

to see the effects of slabutamol and IV furosemide in the treatment of transient tachypnea of newborn

NCT ID: NCT03208764 Completed - Clinical trials for Mycobacterium Abscessus Infection

Inhaled Nitric Oxide for Patients With MABSC

Start date: July 24, 2017
Phase: Phase 2
Study type: Interventional

A Prospective, Open labeled, multi-Center, Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently via Inhalation to Subjects with NTM (specifically MABSC) Nitric Oxide (NO) has been shown to play a critical role in various biological functions. In the airways, NO is considered to play a key role in the innate immune system in which the first-line of host defense against microbes is built. In vitro studies suggested that NO, in part per million (ppm) concentrations, possesses anti-microbial activity against a wide variety of phyla including fungi, and antibiotic-resistance bacteria. In this study the investigators wish to evaluate the efficacy, safety and tolerability of 160 ppm Nitric Oxide intermittently delivered via inhalation to subjects infected with Non-tuberculosis mycobacteria (NTM), specifically with MABSC.

NCT ID: NCT03208478 Completed - Pain, Postoperative Clinical Trials

Pain Control for Anterior Cruciate Ligament Reconstruction Patients With Adductor Canal or Femoral Perineural Infusions

Start date: June 18, 2018
Phase: N/A
Study type: Interventional

Nerve blocks are used to provide pain control after moderately painful orthopedic surgeries. Anterior Cruciate Ligament (ACL) reconstruction with patellar autograft is a painful orthopedic procedure performed after traumatic injury to the knee. Many patients undergoing ACL reconstruction receive a nerve block as part of their anesthetic care. These blocks can be performed in different locations along the femoral nerve, with advantages and disadvantages to each location. Recently published evidence indicates that there is no short-term difference in pain control between the two commonly-targeted locations ("Adductor Canal" and "Femoral"). However, studies involving patients undergoing total knee arthroplasty indicate that femoral blocks provide better pain control with movement than adductor canal blocks. As many patients undergoing ACL reconstruction use continuous passive motion (CPM) machines as part of rehabilitation starting on post-operative day one, the investigators hypothesize that pain control and quality of recovery in the first 48 hours after surgery will be superior with a continuous femoral block than with a continuous adductor canal block. The investigators plan to study this by randomizing patients presenting for ACL reconstruction to receive either a continuous femoral or continuous adductor canal block (both considered adequate means of pain control), and following them to 48 hours to determine the level of pain, quality of recovery score, opioid use, and CPM compliance.

NCT ID: NCT03208309 Completed - Clinical trials for Diabetes Mellitus, Type 2

Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin

Start date: January 2013
Phase: Phase 2
Study type: Interventional

Considering that, Diacerein is on the market for 16 years being used continuously in elderly patients with osteoarthritis without experience significant side effects, and considering the anti-hyperglycemic effect and the improvement in the insulin resistance observed in animal models of type 2 diabetes treated with this medicine. The aim of this study is to investigate the effect of Diacerein, a medication with anti-osteoarthritic properties and moderately analgesic activity, anti-inflammatory and antipyretic, which demonstrates inhibit properties for the synthesis of pro-inflammatory cytokines such as interleukin 1 (IL-1). Administered for 12 weeks and the effect in the glycemic and metabolic control in patients with diabetes mellitus 2 and secondary failure to metformin treatment.

NCT ID: NCT03208270 Completed - Clinical trials for Extracorporeal Membrane Oxygenation

Antithrombin Supplementation in ECMO

Start date: July 28, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

Bleeding is the most feared complication during extracorporeal membrane oxygenation (ECMO) and is associated with high dosing of heparin. There is no consensus on antithrombin (AT) supplementation during ECMO. However, AT is needed by heparin to properly anticoagulate. We hypothesize that maintaining normal antithrombin levels during ECMO is associated with a less heparin dosing and more adequate level of anticoagulation.

NCT ID: NCT03208205 Completed - Clinical trials for Pediatric Rhegmatogenous Retinal Detachment

Outcomes of Vitrectomy in Pediatric Retinal Detachment With Proliferative Vitreoretinopathy

Start date: January 1, 2006
Phase: N/A
Study type: Observational

The aim of this study is to report outcomes of pars plana vitrectomy (PPV) in pediatric retinal detachment (RD) accompanied with proliferative vitreoretinopathy (PVR) as well as complications and factors influencing the final anatomical and functional results. This is retrospective consecutive case series of 14 eyes treated with primary PPV for RD repair. Average postoperative follow-up period is 34 months.